Twenty-three patients with organ-confined, low-risk prostate cancer have been treated with MR-guided focused ultrasound in clinical trials, showing promising initial results.

The goal of the trials is to demonstrate the feasibility of using the ExAblate® MR-guided Focused Ultrasound (MRgFUS) system in endorectal prostate treatments and to assess the safety and preliminary effectiveness of the treatment. The trials were approved by local ethic committees.

Clinical trials are ongoing at four sites: Sapienza University of Rome, Italy; The National Cancer Centre Singapore; The NN Petrov Institute of Oncology, St. Petersburg, Russia; and the Jaslok Hospital and Research Center, Mumbai, India. InSightec will soon be expanding the prostate clinical trials to additional locations.

Read more on the clinical trials.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email